AKT1 and breast cancer: We demostrated that the blockade of PI3K/Akt pathway, which is hyper-activated in PI3Ka-mutated human breast cancer cells, concomitantly to the blockade of microtubules, enhances the apoptotic response as compared to single agent treatment.